Helena Fohlin
Linkoeping, E 58185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Adherence to oral antineoplastic agents, an overview and meta-analysis.
Journal: The oncologist
Published: December 25, 2025
Long-term benefit from adjuvant tamoxifen therapy for ER+ HER2- breast cancer by PR positivity.
Journal: International journal of cancer
Published: July 05, 2025
Impact of assigned care providers on involvement, information, and emotional support to cancer patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 02, 2025
Impact of assigned care providers on involvement, information, and emotional support to cancer patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 02, 2025
Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 05, 2024
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy.
Journal: Breast (Edinburgh, Scotland)
Published: May 21, 2023
Patient reported experiences of Swedish patients being investigated for cancer during the Covid-19 pandemic.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 07, 2023
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 25, 2022
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up.
Journal: Breast (Edinburgh, Scotland)
Published: May 26, 2021
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Journal: British journal of haematology
Published: June 04, 2019
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer.
Journal: Molecular and clinical oncology
Published: April 09, 2019
Last Updated: 09/26/2026